Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Needham Maintains Buy on NuVasive, Lowers Price Target to $53

Needham analyst David Saxon maintains NuVasive (NASDAQ:NUVA) with a Buy and lowers the price target from $67 to $53.
byBenzinga Newsdesk
September 30, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Needham analyst David Saxon maintains NuVasive (NASDAQ:NUVA) with a Buy and lowers the price target from $67 to $53.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0